The mRNA vaccine BNT162b2 elicits high levels of IFN-γ producing CD8+ T cells in the peripheral blood specific for the spike glycoprotein receptor binding domain, which were observed after booster immunization; these frequencies were also notably higher than as observed in individuals who had developed and recovered from COVID-19 [41]. Here, CD8A is linked to COVID-19.